STAT+: While other states, countries have biotech envy, Massachusetts can’t find enough workers
While other states and nations came to the global BIO 2023 convention in Boston this…
Category: Medicine
STAT+: Pharmalittle: U.K. launches pilot to expand access to weight loss drugs; European Union approves RSV vaccine
Top of the morning to you, and a fine one it is. Well, sort of….
STAT+: Google strikes deal with Mayo Clinic to comb patient records using generative AI
Google will embed its generative AI technology into computer systems at Mayo Clinic and other…
Akili Interactive releases video game treatment for adult ADHD with no prescription required
Following positive top-line data released in May, Akili Interactive announced it will release its video…
Opinion: How the conversation about moral injury in health care is changing
In the new book “If I Betray These Words,” I tell the story, with Simon…
.jpg)
Opinion: Listen: Why forced treatment can’t fix substance use disorder
When a loved one is living with serious substance use disorder and refuses to get…
STAT+: ASCO showcased the payoff for new cancer medicines: longer lives
CHICAGO — Well, that’s a wrap. The biggest meeting in cancer research — and, really,…
Opinion: Want to help with medical breakthroughs? Donate some extra cells to a biobank
Right now, it’s possible that cells from my body are growing in a lab somewhere…
STAT+: Buoyed by cancer advances, new ASCO president also stresses honest prognosis
CHICAGO — As a busy weekend at the American Society of Clinical Oncology annual meeting…
STAT+: With digital therapeutics businesses flailing, the industry descends on D.C. to make the case for coverage
This week, the leading advocacy group for digital therapeutics companies is gathering the industry’s leaders…
GSK’s RSV vaccine wins European approval
LONDON — The European Commission approved GSK’s RSV vaccine, the company said Wednesday, bringing to…
STAT+: FDA will allow troubled chemotherapy maker to resume distribution of cancer drugs in short supply
After finding a “cascade of failures” at a manufacturing plant run by a key chemotherapy…
How a digital biomarker study failed, Apple’s health updates, and Carbon’s AI-driven EHR
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Biotech’s trade secrets face growing threat from foreign influences, science leaders warn
BOSTON — While most panel discussions at the Biotechnology Innovation Organization’s international convention tend to…
STAT+: Biogen board and C-suite are in step as they eye M&A opportunities, new CEO says
As Biogen’s new CEO Chris Viehbacher pours over Biogen’s books and scouts out M&A deals,…
‘Tantamount to extortion:’ Merck sues U.S. government over Medicare negotiation program
WASHINGTON — Merck on Tuesday sued to stop the federal government from implementing a new…
STAT+: Pharmalittle: Merck sues U.S. to halt Medicare drug-price negotiation; FDA oncology head wants advisory panels to keep voting on new drugs
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Novocure’s electric fields device prolongs survival in lung cancer, but doubts remain
CHICAGO — A medical device made by Novocure that creates electric fields in the lungs…
STAT+: Medicare taps acting official to head up its new drug price negotiations
WASHINGTON — Medicare has chosen a Center for Medicare and Medicaid Innovation official to temporarily…
Academia’s postdoc system is teetering, imperiling efforts to diversify life sciences
For young life scientists hoping to land a prestigious faculty job in academia, postdoctoral research…
STAT+: The woman behind AstraZeneca’s cancer winning streak
CHICAGO — It was the kind of moment scientists who develop new medicines wait their…
Opinion: When should hospitals require masks?
Is the pandemic over? On the one hand, Covid-19 is clearly still with us. In…
Opinion: Four communication lessons we learned the hard way during the pandemic
Now that the Covid-19 public health emergency has ended, it’s awfully tempting to put the…
STAT+: More than 200 FDA staffers have retired in less than a year
WASHINGTON — More than 230 people have retired from the Food and Drug Administration since…
Watch: Why do we get seasonal allergies?
There’s nothing better than a beautiful spring day after a long, cold winter. But there’s…
STAT+: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel
The Food and Drug Administration has removed a neurologist with financial ties to Biogen and…
STAT+: FDA oncology head wants advisory panels to keep voting on new drugs
CHICAGO — As commissioner of the Food and Drug Administration, Robert Califf has made clear…
STAT+: UnitedHealth starts bidding war with $3.3 billion offer for Amedisys
There’s now a two-party showdown for one of the largest home health companies in the…
STAT+: Ted Love, BIO’s first Black board chair, aims to rehab biotech’s image in Washington
WASHINGTON — Ted Love has pretty much done everything there is to do in biotech. He’s…
STAT+: Gilead’s CAR-T therapy prolongs survival in key blood cancer trial
CHICAGO — Yescarta, the CAR-T therapy made by the Kite unit of Gilead Sciences, prolonged…
STAT+: Bellerophon Therapeutics trial fails despite innovative digital endpoint
In an important reminder that plugging digital tools into a clinical trial will not magically…
‘We arguably saved their lives’: Newborn DNA-sequencing reveals elevated cancer risks for parents
Ten years ago, clinicians in a handful of hospitals around the United States began sequencing…
STAT+: Carbon Health is already using AI to write patient records
SAN FRANCISCO — Primary care tech startup Carbon Health is using artificial intelligence to listen…
STAT+: Pharmalittle: AstraZeneca lung cancer drug halves death risk; 400 Grail patients incorrectly told they may have cancer
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: To push antibiotic makers to be more green, a new system will certify manufacturing practices
In response to concerns about pollution caused by antibiotic production, an industry group is launching…
Akero’s NASH drug combined with Ozempic cut liver fat in small study
GLP-1s, a class of drugs including Ozempic and Wegovy that have become widely popular for…
For many who use power wheelchairs, CMS decision just made seat elevation much less expensive
This article is adapted from STAT’s latest report, Decoding Medicare: 10 key coverage decisions and…
Opinion: How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra
Since a Texas judge’s decision dropped earlier this spring, Braidwood v. Becerra has sent shudders…
STAT+: How Blue Cross Blue Shield insurers ratcheted up profits in 2022
A $203 million tax refund for Blue Cross Blue Shield of North Carolina. Nearly $1.5…
STAT+: Keytruda’s benefits, a breast cancer win, the ‘dom-zim doublet’: Weekend wrap-up from ASCO
CHICAGO — The annual meeting of the American Society of Clinical Oncology is back in…
Listen: For Long Island mothers, community efforts address ‘an injustice made purposefully invisible’
In the third episode of “Color Code,” we take a look at efforts on Long…
STAT+: Biotechs face challenges as the industry’s annual bash returns to Boston
The world has changed since 2018 when the Biotechnology Innovation Organization last brought its annual…
STAT+: ‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug
CHICAGO – Giving the AstraZeneca drug Tagrisso to patients with non-small cell lung cancer who…
STAT+: Targeted drug greatly slows progression of a brain cancer
CHICAGO – An experimental drug dramatically slowed the growth of glioma, a type of brain…
STAT+: Immunogen drug prolongs survival of women with advanced ovarian cancer
CHICAGO — An antibody that delivers chemotherapy directly to tumor cells extended the lives of…
Cross-border ‘twinning programs’ may reduce survival disparities for childhood leukemia
A few miles can mean a life or death difference to children with cancer, if…
Biden plans to pick Mandy Cohen to lead CDC
WASHINGTON — President Biden plans to tap longtime federal and state health official Mandy Cohen…
STAT+: Pharmalittle: Medicare holds firm on Alzheimer’s drug coverage policy; Pfizer says antibiotic combo can treat some superbugs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Novartis drug reduces breast cancer recurrence, but experts may debate results
Kisqali, a breast cancer pill made by Novartis, reduced the risk of recurrence of the…
Studies show top surgery is safe for fat patients, but some surgeons still mandate weight loss
Vince Wescott was ready for top surgery. He had the cash saved up, he’d gotten…